Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Buying Wyeth would boost Pfizer's revenues, but it won't help with the litany of marketing challenges and other problems plaguing Big Pharma
Buying Wyeth would boost Pfizer's revenues, but it won't help with the litany of marketing challenges and other problems plaguing Big Pharma
Buying Wyeth would boost Pfizer's revenues, but it won't help with the litany of marketing challenges and other problems plaguing Big Pharma
Submitted by
admin
on February 10, 2009 - 7:38am
Source:
Businessweek
News Tags:
Wyeth
Big Pharma
Pfizer
buyouts
Headline:
Buying Wyeth would boost Pfizer's revenues, but it won't help with the litany of marketing challenges and other problems plaguing Big Pharma
Do Not Allow Advertisers to Use My Personal information
